IBL HealthCare Limited (PSX:IBLHL)
Pakistan · Delayed Price · Currency is PKR 42.24
-0.28 (-0.66%)
At close: Sep 29, 2026
IBL HealthCare Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 4,162 | 5,224 | 5,363 | 2,648 | 2,324 | 3,374 | |
Market Cap Growth | -14.63% | -2.60% | 102.52% | 13.95% | -31.13% | -43.86% |
Enterprise Value | 3,461 | 5,472 | 5,723 | 2,772 | 2,576 | 3,570 |
Last Close Price | 42.24 | 53.02 | 54.43 | 26.88 | 23.59 | 33.54 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 18.86 | 23.70 | 25.74 | 350.52 | 7.52 | 11.14 |
PS Ratio | 0.90 | 1.13 | 1.24 | 0.74 | 0.58 | 0.92 |
PB Ratio | 1.64 | 2.05 | 2.31 | 1.25 | 1.10 | 1.81 |
P/TBV Ratio | 1.64 | 2.06 | 2.31 | 1.25 | 1.11 | 1.82 |
P/FCF Ratio | 6.37 | 8.00 | - | 4.68 | 95.49 | 60.74 |
P/OCF Ratio | 6.31 | 7.92 | - | 4.66 | 85.54 | 59.36 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.75 | 1.19 | 1.32 | 0.77 | 0.64 | 0.98 |
EV/EBITDA Ratio | 7.88 | 12.45 | 12.78 | 17.72 | 4.20 | 6.20 |
EV/EBIT Ratio | 7.99 | 12.63 | 12.87 | 18.08 | 4.23 | 6.26 |
EV/FCF Ratio | 5.30 | 8.38 | - | 4.89 | 105.87 | 64.26 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.07 | 0.01 | 0.14 | 0.14 |
Debt / EBITDA Ratio | 0.06 | 0.06 | 0.35 | 0.14 | 0.48 | 0.46 |
Debt / FCF Ratio | 0.04 | 0.04 | - | 0.04 | 12.23 | 4.81 |
Net Debt / Equity Ratio | -0.28 | -0.28 | -0.02 | -0.17 | 0.10 | 0.09 |
Net Debt / EBITDA Ratio | -1.59 | -1.59 | -0.11 | -2.26 | 0.33 | 0.28 |
Net Debt / FCF Ratio | -1.07 | -1.07 | 0.18 | -0.62 | 8.29 | 2.94 |
Asset Turnover | 1.15 | 1.15 | 1.18 | 1.05 | 1.24 | 1.36 |
Inventory Turnover | 2.75 | 2.75 | 2.65 | 2.53 | 2.49 | 2.85 |
Quick Ratio | 1.58 | 1.58 | 1.19 | 1.44 | 1.03 | 1.15 |
Current Ratio | 2.30 | 2.30 | 2.02 | 2.24 | 2.05 | 2.20 |
Return on Equity (ROE) | 9.06% | 9.06% | 9.39% | 0.36% | 15.56% | 17.42% |
Return on Assets (ROA) | 6.73% | 6.73% | 7.58% | 2.79% | 11.76% | 13.27% |
Return on Invested Capital (ROIC) | 10.39% | 11.56% | 12.18% | 0.52% | 18.94% | 18.79% |
Return on Capital Employed (ROCE) | 16.90% | 16.90% | 19.00% | 7.30% | 28.90% | 30.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 5.30% | 4.22% | 3.89% | 0.29% | 13.30% | 8.97% |
FCF Yield | 15.70% | 12.51% | -5.20% | 21.39% | 1.05% | 1.65% |
Dividend Yield | - | - | - | - | - | 1.96% |
Payout Ratio | 0.01% | 0.01% | 0.08% | 0.56% | 20.11% | 17.05% |
Buyback Yield / Dilution | 0.13% | 0.13% | - | - | 0.00% | -0.00% |
Total Shareholder Return | 0.13% | 0.13% | - | - | - | 1.96% |